#IDDF2025

Speaker

Enrik AGUILA
Enrik AGUILA
St. Luke’s Medical Center Global City and Ospital ng Maynila Medical Center
Philippines
Enrik AGUILA
Enrik AGUILA
St. Luke’s Medical Center Global City and Ospital ng Maynila Medical Center
  • Consultant Gastroenterologist and Advanced Endoscopist
  • Head of the Research Committee, Gastroenterology Departments
  • Faculty Member, Ateneo School of Medicine and Public Health (ASMPH)
Enrik Aguila is a consultant gastroenterologist and advanced endoscopist at St. Luke’s Medical Center Global City and Ospital ng Maynila Medical Center. He also serves as the head of the research committee in the Gastroenterology departments of both institutions. In addition, he is a faculty member at the Ateneo School of Medicine and Public Health (ASMPH).

He earned his MD-MBA degree from ASMPH in 2014, and received board certification in gastroenterology and digestive endoscopy after completing his fellowship training at St. Luke’s Medical Center Global City in 2020. He subsequently underwent advanced endoscopy training in Adelaide, Australia, under an APAGE Clinician-Scientist Training scholarship. Most recently, he completed a two-month clinical observership in advanced endoscopy as a Berenson Scholar at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, Massachusetts, USA, supported by the Berenson International Scholarship and a JGHF Grant.

Dr. Aguila is an active member of several professional organizations. He serves on various committees of the Philippine Society of Gastroenterology and Philippine Society of Digestive Endoscopy. Internationally, he is a member of the Emerging Leaders Committee of the Asian Pacific Association of Gastroenterology and part of the 4th cohort of the World Endoscopy Organization’s Emerging Stars program. He also serves as Associate Editor of the Philippine Journal of Gastroenterology and Deputy Social Media Editor for the Journal of Gastroenterology and Hepatology.

In addition, Dr. Aguila is a faculty member of both the Asian Novel Bio-Imaging and Intervention Group (ANBIIG) and the Academy of Endoscopy—organizations dedicated to advancing endoscopic education and improving patient care across the region through initiatives such as simulation-based mastery learning (SBML). He completed an SBML certification course at the Northwestern University in Chicago, Illinois, as part of his dedication to high-quality endoscopic training and education.
Johan BURISCH
Johan BURISCH
Copenhagen University Hospital
Denmark
Johan BURISCH
Johan BURISCH
Copenhagen University Hospital
  • Gastroenterologist, Department of Gastroenterology
Johan Burisch is a Professor and Consultant in Gastroenterology at Hvidovre Hospital and the University of Copenhagen. His research focuses on inflammatory bowel disease (IBD), with a particular interest in disease epidemiology, disease course, and precision medicine. He leads several national and international projects, including multi-omics studies aimed at identifying new IBD subtypes to support individualized treatment strategies. Johan is also involved in developing and evaluating digital health interventions to improve care for patients with mild to moderate IBD. He is a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).
Shun-tian CAI
Shun-tian CAI
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University
Vice Chairman
China
Shun-tian CAI
Shun-tian CAI
Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University
  • Deputy Director
Vice Chairman
  • Youth Committee, Gastroenterology Branch, Cross-Strait Medical and Health Exchange Association
- MD, Associate Chief Physician, Associate Professor
- Deputy Director, Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University.
- Vice Chairman, Youth Committee, Gastroenterology Branch, Cross-Strait Medical and Health Exchange Association.
- Committee Member, Tumor Enterology Committee, Chinese Anti-Cancer Association.
- Vice Leader, Artificial Intelligence Group, Gastroenterology Physicians Branch, Fujian Provincial Physicians Association.
- Vice Leader, Minimally Invasive Intervention Group, Gastroenterology Branch, Fujian Medical Association.
- Committee Member, Youth Committee, Digestive Endoscopy Branch, Fujian Medical Association.
- Vice Chairman, Youth Committee, Gastroenterology Branch, Xiamen Medical Association.
- Committee Member, Xiamen Gastroenterology Quality Control Center.
- Secretary, Digestive Endoscopy Branch, Xiamen Medical Association.
Shannon CHAN
Shannon CHAN
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Shannon CHAN
Shannon CHAN
The Chinese University of Hong Kong, Hong Kong
  • Assistant Professor, Division of Upper Gastrointestinal & Metabolic Surgery
Shannon Chan is currently an Assistant Professor in the Division of Upper Gastrointestinal & Metabolic Surgery of The Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong in 2007. She completed general surgical training and received fellowships of the College of Surgeons of Hong Kong and Royal College of Surgeons of Edinburgh in 2014. Dr. Chan’s interest is in gastric and esophageal cancers, mainly focusing in the laparoscopic and robotic approach. She did her overseas training in National Cancer Centre in Tokyo, Yonsei University in Seoul and also Amsterdam Medical Centre in Amsterdam. Her research interests include upper gastrointestinal surgical oncology and advanced diagnostic and therapeutic endoscopy especially in interventional endoscopic ultrasound. She also has special interests in peritoneal surface malignancy and has started a multidisciplinary team for these rare, yet important group of patients. She is a member of the stomach and duodenal diseases subcommittee of the World Endoscopy Organisation (WEO) and is a reviewer for Digestive Endoscopy and Surgical Endoscopy. She has published over 20 peer-reviewed journals.  


Apart from her research interest, Dr. Chan has also devoted herself to humanitarian aid work. In 2014, she joined the Médecins Sans Frontières (MSF, also named Doctors without borders). MSF is an international humanitarian non-governmental organization working in war-torn and under-developed regions. Dr. Chan joined their surgical missions to South Sudan from Oct 2016 - Dec 2016 and to Yemen from Dec 2019 to Feb 2020. After her return, she has further affirmed her commitment to providing humanitarian aid to the less developed parts of the world.
Wah-kheong CHAN
Wah-kheong CHAN
University of Malaya
University of Malaya Medical Centre
Malaysia
Wah-kheong CHAN
Wah-kheong CHAN
University of Malaya
  • Professor, Department of Medicine
University of Malaya Medical Centre
  • Director of the Division of Gastroenterology and Hepatology
Wah-kheong Chan is Professor of Medicine, Director of the Division of Gastroenterology and Hepatology, and Senior Consultant Gastroenterologist and Hepatologist at the University of Malaya, the University of Malaya Medical Centre and the University of Malaya Specialist Centre. He served as an Executive Committee Member for the Malaysian Society of Gastroenterology and Hepatology (MSGH) between 2015 and 2021. He was the Scientific Co-Chair and a core member of the Organizing Committee for the Asian Pacific Digestive Week (APDW) 2021. He completed two terms as Associate Editor for the Journal of Gastroenterology and Hepatology between 2018 and 2023, and is a current member of the Editorial Board for Clinical Gastroenterology and Hepatology, Alimentary Pharmacology and Therapeutics, and Clinical and Molecular Hepatology. He has published numerous full papers in peer-reviewed journals and presented in both local and international conferences. His main area of research interest is metabolic dysfunction-associated steatotic liver disease.
 
Harry CHEN
Harry CHEN
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Tzu Chi University
Taiwan, China
Harry CHEN
Harry CHEN
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
  • Director of the Division of Gastroenterology and Hepatology
Tzu Chi University
  • Professor of Medicine
Harry Chen is Director of the Division of Gastroenterology and Hepatology at Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. He concurrently holds the position of Professor of Medicine at Tzu Chi University. He is the current present of Taiwan Neurogastroenterology and Motility Society. He is currently appointed to be a member for scientific committee and GC in ANMA, and AGA UGI council. He graduated from the Department of Medicine, National Yang Ming University in 1992 and subsequently obtained a postgraduate medical degree at the University of New South Wales (PhD of Medicine), Australia in 2009. He also gained experience working overseas as researcher at the Gastrointestinal Motility Research Center, Lynn Health Science Institute, Oklahoma, USA (2000-2001), and at Division of Gastroenterology, St George’s Hospital, New South Wales, Australia (2006-2007).

His major interests in the research include esophageal physiology, the pathogenesis of GERD, and GI motility. Professor Chen has published over 150 articles in renowned medical journals, such as Gastroenterology, GUT and American Journal of Gastroenterology, and wrote book chapters on GRED and GI motility. In addition, Professor Chen has presented numerous scientific presentations at local and international conferences, and has garnered several research distinction awards at Digestive Disease Week in the United States.
Ye CHEN
Ye CHEN
Shenzhen Hospital, Southern Medical University
Integrative Microecology Medical Center
China
Ye CHEN
Ye CHEN
Shenzhen Hospital, Southern Medical University
  • Vice president
Integrative Microecology Medical Center
  • Professor of Medicine and Chief
- Vice president of Shenzhen Hospital, Southern Medical University
- Professor of Medicine, Chief of Integrative Microecology Medical Center
- Member of Standing Committee of Chinese Society of Gastroenterology(CSG)
- Leader of Chinese Helicobacter Study Group of CSG
- Chairperson of Gastroenterology Branch of Guangdong Medical Doctor Association

Research interests
- H.pylori infection
- Inflammatory bowel diseases(IBD)
- C.difficile infection
Cheng-tang CHIU
Cheng-tang CHIU
Chang Gung Memorial Hospital
Taiwan, China
Cheng-tang CHIU
Cheng-tang CHIU
Chang Gung Memorial Hospital
  • Professor, Department of Gastroenterology and Hepatology
Dr. Chiu was the President of the Digestive Endoscopy Society of Taiwan(DEST) during 2022/04～2025/04.
Vice-Chairman, Gastroenterology Branch, Cross-Strait Medical and Health Exchange Association.


Dr. Chiu has been an active gastroenterologist, medical educator and medical administrator, involving in many clinical studies’ principal investigator and he centered his research focus on the field of inflammatory bowel disease(IBD) and gut microbiota. He has authored or coauthored nearly 270 original articles, book chapters and reviews on a wide range of medical and digestive disease topics.
Philip CHIU
Philip CHIU
The Chinese University of Hong Kong, Hong Kong
Health Bureau of HKSAR Government, Hong Kong
Hong Kong, China
Philip CHIU
Philip CHIU
The Chinese University of Hong Kong, Hong Kong
  • Dean of the Faculty of Medicine, Shun Hing Education and Charity Fund Professor of Robotic Surgery
  • Director of Multi-Scale Medical Robotics Center
  • Director of Endoscopy Center and Institute of Digestive Disease
Health Bureau of HKSAR Government, Hong Kong
  • Member of the Steering Committee of Health and Medical Innovation Development
Professor Philip Chiu is the Dean of the Faculty of Medicine, Shun Hing Education and Charity Fund Professor of Robotic Surgery, Professor of Division of Upper GI and Metabolic Surgery, Director of Multi-Scale Medical Robotics Center, and Director of Endoscopy Center, Institute of Digestive Disease of The Chinese University of Hong Kong.



Professor Chiu is a pioneer in minimally invasive and robotic surgery, having performed Hong Kong’s first endoscopic submucosal dissection (ESD) for the treatment of early gastrointestinal cancers in 2004, as well as the world’s first robotic gastric ESD and colorectal ESD in 2011 and 2020 respectively. Professor Chiu has received numerous prestigious awards, including the State Scientific Technology and Progress Award from People’s Republic of China in 2007, two Gold Medals with Congratulations from Jury at the International Exhibitions of Inventions Geneva (2019, 2023), Spirit of Hong Kong Award on Innovation in 2020, and Honorary Membership of the European Association of Endoscopic Surgery in 2023.
Charing Chong
Charing Chong
Prince of Wales Hospital, Hong Kong
Hong Kong, China
Charing Chong
Charing Chong
Prince of Wales Hospital, Hong Kong
  • Associate Consultant, Department of Surgery
Charing Chong is currently an Associate Consultant in the Department of Surgery at Prince of Wales Hospital, the Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong and received her postgraduate surgical training primarily at Prince of Wales Hospital in Hong Kong. She is a fellow of the Royal College of Surgeons of Edinburgh and a member of several professional organizations, including the International Hepato-Pancreato-Biliary Association (IHPBA), the International Association of Surgeons, Gastroenterologists, and Oncologists, the Hong Kong Society of Hepatobiliary and Pancreatic Surgery, the Hong Kong Society of Robotic Surgery, and the Asian EUS Group. She also serves as the honorary treasurer of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery.

After obtaining her fellowship in 2010, she received further training in surgical oncology at Johns Hopkins Hospital and in robotic surgery at the University of Illinois at Chicago. She also received her EUS training at Changhai Hospital in Shanghai and Asan Medical Center in Seoul.

She specializes in general surgery, specifically hepato-biliary and pancreatic surgery. Her main research interests are in the surgical management of hepato-biliary and pancreatic cancer. She is also interested in various hepato-biliary and pancreatic diseases, particularly interventional EUS and minimally invasive hepato-biliary and pancreatic surgery.
Anna Mae DIEHL
Anna Mae DIEHL
Duke University
USA
Anna Mae DIEHL
Anna Mae DIEHL
Duke University
  • Florence McAlister Professor of Medicine
Dr. Anna Mae Diehl received her Bachelors of Science and MD degrees at Georgetown University in 1974 and 1978, respectively. She then moved to Johns Hopkins for her internship and residency in internal medicine from 1978-1981, followed by gastroenterology fellowship training from 1981-1984. She was a member of the US Army and had her first faculty appointment at the United State Health Services University from 1984-1987. After completing her military service, she joined the faculty at Georgetown University/Washington Veterans Administration Medical Center as an Assistant Professor of Medicine/gastroenterologist in 1987. In 1990, she was recruited back to Johns Hopkins and rose through the ranks to become a tenured Professor of Medicine in 1997. She was recruited to Duke to chair the GI Division there in 2004, a position she held for the next decade.

Currently, Dr. Diehl is the Florence McAlister Professor of Medicine at Duke University. She is a physician scientist and clinical hepatologist. Her lab-based research activities focus on basic mechanisms of liver repair and complement her translational/clinical research programs in alcoholic- and nonalcoholic fatty liver disease. Dr Diehl’s basic research program has enjoyed uninterrupted NIH RO1 support since 1990. She has been the Principal Investigator for the NASH CRN UO1 clinical research program at Duke since its inception almost 20 years ago, as well as the Duke PI for the Liver Cirrhosis UO1 Network that began in 2021.

Dr. Diehl is viewed internationally as an authority on liver regeneration and fatty liver disease. Her research contributions to the fields of regenerative medicine, alcohol-related liver disease and NAFLD have been acknowledged by election to membership in the American Society for Clinical Investigation and Association of Academic Professors, as well as awards such as an NIH/NIAAA Merit Award, the NIAAA Mendelson Award, the Duke Distinguished Faculty Award, and the AASLD Distinguished Scientific Achievement Award. She has also been the primary research mentor for over 70 individuals and received mentoring awards from Johns Hopkins, Duke and the AGA.
Emad EL-OMAR
Emad EL-OMAR
University of New South Wales
GUT, BMJ Journals
Australia
Emad EL-OMAR
Emad EL-OMAR
University of New South Wales
  • Director, St George & Sutherland Clinical School
GUT, BMJ Journals
  • Editor in Chief
Emad El-Omar graduated in Medicine from Glasgow University, Scotland, and trained as a gastroenterologist. He worked as a Visiting Scholar/Scientist at Vanderbilt University, TN, and National Cancer Institute, MD, USA, and was Professor of Gastroenterology at Aberdeen University, Scotland, for 16 years before taking up the Chair of Medicine at St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia. He is the Editor in Chief of the journal Gut. His research interests include the gut microbiome, inflammation driven GI cancer and IBD. He is the Director of the Microbiome Research Centre at St George Hospital, Sydney.
Jian-gao FAN
Jian-gao FAN
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
China Pharmaceutical Biotechnology Association
China
Jian-gao FAN
Jian-gao FAN
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
  • Professor and Director of Department of Gastroenterology
China Pharmaceutical Biotechnology Association
  • President of Chronic Disease Management Branch
Dr. Jian-Gao Fan received his Ph.D. in 1997 at Shanghai Jiao Tong University School of Medicine. He was a Gastroenterologist at Shanghai 1st People’s Hospital from 1997 to 2007, and visiting scholar of Australian National University from 2007 to 2008. And then he is Professor of Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, and academic leader of Shanghai Key Lab of Pediatric Gastroenterology and Nutrition.
Currently, he is president of Chronic disease management branch of China Pharmaceutical Biotechnology Association, Editor-in-Chief of Journal of Practical Hepatology (in Chinese), and executive Associate Editor-in-Chief of World J Gastroenterol, Associate Editor of Clin Mol Hepatol., J Clin Trans Hepatol.
His main research interests are in the fields of metabolic dysfunction and chronic liver diseases with 11 China National Grants as Principle Investigator. He has published 180 articles in SCI journals as the first and/or correspondent author, i.e, Nat Rev GH., Gastroenterology, Hepatology, J Hepatol, and 9 book chapters in English, with H-index over 76.
Jing-Yuan FANG
Jing-Yuan FANG
Renji Hospital, Shanghai Jiaotong University
Shanghai Institute of Digestive Disease
China
Jing-Yuan FANG
Jing-Yuan FANG
Renji Hospital, Shanghai Jiaotong University
  • Chief of Digestive Disease Center
Shanghai Institute of Digestive Disease
  • Director
Prof. Jing-Yuan Fang got the doctor degree from Shanghai Second Medical University on 1996. He worked NIH/NCI, University of Michigan and University of Connecticut, USA as a post-doctoral fellow or a visiting scholar from 1998 to 2001 and 2004. Now, he is the Chief of Digestive Disease Center, Renji Hospital, Shanghai Jiaotong Univ School of Med; he also is the Director of Shanghai Institute of Digestive Disease. His current research interests focus on the gut microbe, the epigenetic modifications, cell signaling pathways during the pathogenesis and prevention of GI cancers. He has published more than 195 papers (Cell, Cell Metab, Cell Host Microbe, Nat Microbiol, Lancet Oncol, Lancet GH, Cancer Discov, Nat Rev Clin Oncol, Gastroenterology, Gut, etc) in English as the corresponding author.
Carlos FRANCISCO
Carlos FRANCISCO
Institute of Digestive and Liver Diseases at St. Luke’s Medical Center
Philippines
Carlos FRANCISCO
Carlos FRANCISCO
Institute of Digestive and Liver Diseases at St. Luke’s Medical Center
  • Consultant
Dr. Carlos Francisco is a consultant at the Institute of Digestive and Liver Diseases at St. Luke’s Medical Center – Global City. He specializes in advanced diagnostic and therapeutic endoscopy, bariatric and metabolic endoscopy, and obesity medicine. He is SCOPE-certified by the World Obesity Federation. Dr. Francisco currently serves as the Director and Chair of the Committee on Basic and Advanced Endoscopy Training of the Philippine Society of Digestive Endoscopy. He is also a faculty member of the Academy of Endoscopy and plays an active role in training endoscopists both locally and internationally. His work focuses on advancing endoscopy training and promoting high quality education in the field of digestive health.
Markus GERHARD
Markus GERHARD
Technical University of Munich
Germany
Markus GERHARD
Markus GERHARD
Technical University of Munich
  • Deputy Director
Professor Gerhard studied medicine in Heidelberg and Hamburg and earned his MD in 1996. From 1997 to 2004 he completed his medical training leading to German medical board certification in internal medicine in the Department of Internal Medicine at Klinikum rechts der Isar. From 2006 he headed a research group in the Department of Internal Medicine at TUM, where he also acquired his postdoctoral teaching qualification (habilitation) in internal medicine in 2009. In 2010 he was appointed associate professor of medical microbiology and immunology at the Institute for Medical Microbiology and Immunology, a unit within TUM. He also serves as academic director of the TUM Venture Lab Healthcare, TUM`s biotech incubator.

The research work of Professor Gerhard explores how pathogens interact with the host in gastrointestinal infections. Professor Gerhard’s research group investigates the mechanisms that suppress the immune response of the host to allow the establishment of chronic infection as well as inflammatory factors involved in the development of cancer, in order to leverage this know-how for the development of novel preventive and therapeutic strategies.

Prof. Gerhard has published > 120 papers, many in prestigious journals such as Nature Medicine, Nature Microbiology, Gastroenterology, GUT etc.
Chun-jun GUO
Chun-jun GUO
Weill Cornell Medicine
USA
Chun-jun GUO
Chun-jun GUO
Weill Cornell Medicine
  • Associate Professor of Microbiology & Immunology in Medicine, Jill Roberts Institute (JRI)
Chun-jun Guo is an Associate Professor at the Jill Roberts Institute (JRI) for Research in IBD and Halvorsen Family Research Scholar at Weill Cornell Medicine. My group uses bioinformatics, molecular genetics, metabolomics, and chemical biology approaches to examine how the microbiota genes and metabolic pathways affect host metabolism and immunity in the context of health and diseases. I am a recipient of the 2019 NIH Director’s New Innovator Award and 2024 NIH Director’s Transformative Research Award, the Scialog Fellow, the 2022 Kenneth Rainin Innovator Award, the 2020 Medical Research Award W. M. Keck Foundation, the 2020 AGA-Allergan Foundation Pilot Research Award in IBD, and one of the three finalists of the 2020 Science & Noster Microbiome Prize.
Agnes HO
Agnes HO
Prince of Wales Hospital
The Chinese University of Hong Kong
Hong Kong, China
Agnes HO
Agnes HO
Prince of Wales Hospital
  • Gastroenterology and Hepatology Specialist, Division of Gastroenterology and Hepatology
The Chinese University of Hong Kong
  • Honorary Clinical Tutor, Faculty of Medicine
Agnes Ho is currently a gastroenterology and hepatology specialist in the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, New Territories East Cluster (NTEC), Hospital Authority and Honorary Clinical Tutor of the Faculty of Medicine, The Chinese University of Hong Kong (CUHK). She has deep interest and enthusiasm in inflammatory bowel disease, nutrition and intestinal ultrasound (IUS).



She graduated from the Faculty of Medicine, Chinese University of Hong Kong in 2017 with Dean’s list and obtained the fellowship in Gastroenterology and Hepatology in 2024. She completed her overseas training in IBD in the IBD center of University of Chicago, Illinois, United States of America in 2024. She also obtained the certification in performing IUS from International Bowel Ultrasound Group in the same year. She received various accolades and grants including the Head List (Merit) from New Asia College of the Chinese University of Hong Kong, Mr. and Mrs. Lam Wing-Tak Scholarship and Young Investigator Research Grant from Hong Kong College of Physician (HKCP).

Dr Ho has published in peer-reviewed journals including the American Journal of Medicine and her work was presented in international conferences such as Asian Pacific association for the study of liver (APASL) and Digestive Disease Week (DDW). In addition, she has been the reviewer of Medicom conference reports in the recent 3 years.
Jacky HO
Jacky HO
Prince of Wales Hospital
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Jacky HO
Jacky HO
Prince of Wales Hospital
  • Associate Consultant, Division of Gastroenterology and Hepatology
The Chinese University of Hong Kong, Hong Kong
  • Honorary Clinical Tutor, Faculty of Medicine
Jacky Ho is an accomplished gastroenterologist serving as an Associate Consultant in the Division of Gastroenterology and Hepatology at the Prince of Wales Hospital and an Honorary Clinical Assistant Professor at the Faculty of Medicine at the Chinese University of Hong Kong.

Dr. Ho graduated from the Chinese University of Hong Kong in 2015 after receiving various awards, including Dean’s List and Distinction in Medicine. He obtained Membership of the Royal Colleges of Physicians (MRCP) in 2019 and became a specialist in gastroenterology and hepatology in 2022.

Dr. Ho is actively involved in professional communities, holding leadership roles in various committees, including the Young Fellow Committee at the Hong Kong College of Physicians and the Young Fellow Chapter of the Hong Kong Academy of Medicine.

Dr. Ho’s clinical expertise focuses on GI motility disorders, as well as advanced diagnostic and therapeutic endoscopies. His research contributions have been published in various respected journals such as Clinical Gastroenterology and Hepatology, Liver International, and Journal of Gastroenterology and Hepatology. Outside his clinical and research commitments, he is also actively involved in developing sustainable endoscopy practices through his role as the PWH Green Endoscopy Committee chairperson and a member of the APAGE Task Force on Green and Sustainability in GI.
Khek-yu HO
Khek-yu HO
National University of Singapore (NUS)
Senior Consultant
Singapore
Khek-yu HO
Khek-yu HO
National University of Singapore (NUS)
  • Professor of Medicine
Senior Consultant
  • National University Hospital (NUH)
Professor Ho is Professor of Medicine, National University of Singapore (NUS); Senior Consultant, National University Hospital (NUH); and Director, Centre for Innovation in Healthcare, National University Health System (NUHS). Besides being an accomplished endoscopist, he is an established international key opinion leader, being conferred the honorary International Life Membership of the Society of Gastrointestinal Endoscopy of India, and made Fellow of Japan Gastroenterological Endoscopy Society, to recognize his significant contributions to the field of gastrointestinal endoscopy. Experienced in spearheading collaboration between researchers in Asia, he was the Founding Chairman of the Asian EUS Group. He also is the Founding Co-Chairs Gut & Obesity in Asia (“Go Asia”) Workgroup, and the US NIH-NCS initiated Asian Barrett’s Consortium.

A proven clinician innovator and experienced entrepreneur, he co-invented the Master and Slave Transluminal Endoscopic Robot (MASTER), which has since been spun-off into the start-up, Endomaster Pte Ltd. He also founded two other start-up companies, Endofotonics Pie Ltd, a molecular AI based realtime diagnostic system, and Endopil Pte Ltd, an ingestible weight loss balloon capsule. He received the Singapore President’s Technology Award in 2012. He has held 6 US-granted patents in medtech products.

He was President of Gastroenterological Society of Singapore in 2005. In recognition of his outstanding contributions to the medical profession as a leading expert, the Ministry of Heath Singapore awarded him the prestigious Distinguished Senior Clinician award 2017. He was conferred the Public Administration Medal (Bronze) 2017 for his distinguished service to public administration.
Akio KATANUMA
Akio KATANUMA
Sapporo Medical University
Japan
Akio KATANUMA
Akio KATANUMA
Sapporo Medical University
  • Associate Professor, Department of Digestive Cancer of Telemedicine and Department of Gastroenterology
Akio Katanuma is currently an Associate Professor the Department of Digestive Cancer of Telemedicine and Department of Gastroenterology at the Sapporo medical university, Sapporo, Japan. He is also Visiting Professor of Tokyo Medical University and Clinical Professor of Sapporo Medical University. He graduated from Sapporo Medical University School of Medicine in 1991 and trained in Muroran Municipal Hospital. He earned his doctoral degree (PhD) at Sapporo Medical University in 2020. Subsequently, Dr. Katanuma underwent training on EUS and ERCP related procedures at Teine-Keijinkai hospital. He was a director of the center for Gastroenterology from 1998 to 2025.
He is an ERCP and EUS expert. His research interests include EUS- and ERCP-related procedures. He has more than 200 peer-reviewed papers published in English. He is currently a Director of the Japan Gastroenterological Endoscopy Society (JGES), Japan Biliary Association (JBA), and a councilor of the Japanese society of Gastroenterology (JSGE), and Japan Pancreas society (JPS).
Eun-soo KIM
Eun-soo KIM
Division of Gastroenterology, School of Medicine, Kyungpook National University
Publication Committee for KASID
South Korea
Eun-soo KIM
Eun-soo KIM
Division of Gastroenterology, School of Medicine, Kyungpook National University
  • Professor
Publication Committee for KASID
  • Director
Eun-soo Kim graduated from Kyungpook National University School of Medicine in Daegu, South Korea, and trained as a gastroenterologist in the Department of Internal Medicine at Kyungpook National University Hospital. He completed his fellowship in the Division of Gastroenterology at Yonsei University Severance Hospital in Seoul, South Korea, and spent a year as a clinical researcher at the Susan and Leonard Feinstein Inflammatory Bowel Disease Center of Mount Sinai in New York, under the supervision of Professor Jean Fred Colombel and Professor Ingar Peter.

Currently, he is a Professor in the Division of Gastroenterology at Kyungpook National University School of Medicine in Daegu. His research interests center on inflammatory bowel disease (IBD), with a focus on monitoring and treatment strategies.

Dr. Kim serves as the Director of the Publication Committee for KASID and is a Deputy Editor of the journal Intestinal Research. He has authored over 50 articles as the primary author in esteemed journals such as Gastroenterology, The American Journal of Gastroenterology, and Journal of Crohn's and Colitis.
Michael KO
Michael KO
Queen Mary Hospital
The University of Hong Kong
Hong Kong, China
Michael KO
Michael KO
Queen Mary Hospital
  • Associate Consultant, Department of Medicine
The University of Hong Kong
  • Honorary Clinical Assistant Professor
Michael Ko graduated with honour from the University of Hong Kong and was awarded distinction in medicine and surgery in 2011. He completed his specialist training in Gastroenterology and Hepatology in 2018. He is currently Associate Consultant at Queen Mary Hospital and Honorary Clinical Assistant Professor of HKU. His expertise covers inflammatory bowel disease, enteroscopy and ERCP. He received his intestinal ultrasound training in Luneberg with Professor Christian Maaser and Tokyo with Dr Shintaro Sagami and is currently accredidated Module 2 trainer of IBUS curriculum in Hong Kong.
Jimmy LAI
Jimmy LAI
The Chinese University of Hong Kong
Hong Kong, China
Jimmy LAI
Jimmy LAI
The Chinese University of Hong Kong
  • Clinical Assistant Professor, Department of Medicine and Therapeutics
Jimmy Lai graduated from the Chinese University of Hong Kong in 2015 with honours. He received training in Gastroenterology and Hepatology in Prince of Wales Hospital and obtained the fellowship of Gastroenterology and Hepatology in 2022. He is now a Clinical Assistant Professor of Faculty of Medicine, CUHK.

Dr. Lai is active in cirrhosis and viral hepatitis research with special interest in portal hypertension. He has published extensively in high-impact journals. With his research findings, he had numerous awards including Prize for Best Original Research by Trainees in 2021 from Hong Kong Academy of Medicine, Young Investigator Research Grant and Best Thesis Award (gold medal) in 2022 and Distinguished Research Paper Award for Young Investigators in 2019 and 2024 from Hong Kong College of Physician, and Investigator Award in Asian Pacific Association for the Study of the Liver in 2024. Dr. Lai was named Distinguished Young Fellows by Hong Kong Academy of Medicine. He is now a member of the Baveno Cooperation and the Co-director of Center for Liver Health, CUHK.
Louis LAU
Louis LAU
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Louis LAU
Louis LAU
The Chinese University of Hong Kong, Hong Kong
  • Assistant Professor (Clinical), Department of Medicine & Therapeutics, Faculty of Medicine
Dr. Lau graduated from Faculty of Medicine, The Chinese University of Hong Kong (CUHK) in 2012. He joined the Department of Medicine and Therapeutics upon graduation and obtained his specialist registration in Gastroenterology and Hepatology in 2019. Since 2021, he has served as an Assistant Professor at CUHK. He completed his research fellowship and visiting professorship at Stanford University in 2024.


Dr. Lau has research interests in gastrointestinal bleeding, advanced endoscopy, big data analytics and artificial intelligence with first- or co-authored publications in high-impact journals including The New England Journal of Medicine, Gastroenterology, Gut and CGH. He currently serves as a Junior Editor of Endoscopy and editorial board members of Gastroenterology and APT.



Recognized as an advanced endoscopist specialized in third space endoscopy, Dr. Lau was selected as an Emerging Star by the World Endoscopy Organization and serves as a faculty member of the Asian Novel Bio-Imaging and Intervention Group (ANBIIG). His international accolades include the National Scholar Award from the United European Gastroenterology Week and the Research Programme Award from The Asian Pacific Association of Gastroenterology. Locally, he has been honored with the Gold Medal Best Thesis Award and the Distinguished Research Paper Award from Hong Kong College of Physicians. He was also nominated as a Distinguished Young Fellow and received the Bronze Medal of Best Original Research from Hong Kong Academy of Medicine.
Wai-keung LEUNG
Wai-keung LEUNG
The University of Hong Kong
Academia Europaea 2025
Hong Kong, China
Wai-keung LEUNG
Wai-keung LEUNG
The University of Hong Kong
  • Li Shu Fan Medical Foundation Professor in Gastroenterology
  • Chief Director of the Clinical Trials Centre
Academia Europaea 2025
  • Member
Professor Leung is a gastroenterologist and is currently the Li Shu Fan Medical Foundation Professor in Gastroenterology and Chief Director of the Clinical Trials Centre of the University of Hong Kong. He was elected to be a Member of the Academia Europaea in 2025. Prof Leung is the current Editor-in-Chief of the HELICOBACTER journal, the immediate past President of the Hong Kong Society of Gastroenterology (2022-2024) and the Treasurer of the Asia Pacific Association of Gastroenterology (2023-2025). He was also the Associate Dean of Research of the LKS Faculty of Medicine of the University between 2018 and 2024.

Professor Leung has a wide research interest in gastroenterology and endoscopy including Helicobacter pylori and gastric carcinogenesis, inflammatory bowel disease, artificial intelligence, and screening colonoscopy. He has published more than 350 original articles as first or corresponding author in leading medical and gastroenterology journals including the Lancet series, Gastroenterology, Gut, and Nature Communications, etc.
Peng LI
Peng LI
Beijing Friendship Hospital affiliated to Capital Medical University
National Clinical Research Center for Digestive Diseases
China
Peng LI
Peng LI
Beijing Friendship Hospital affiliated to Capital Medical University
  • Vice President
National Clinical Research Center for Digestive Diseases
  • Deputy Director
  • Deputy Director of the Digestive Department
Chief physician, professor, doctoral supervisor, currently vice president of Beijing Friendship Hospital affiliated to Capital Medical University, deputy director of National Clinical Research Center for Digestive Diseases, deputy director of the digestive department. Member of the Standing Committee of the Digestive Disease Branch of the Chinese Medical Association, chief medical officer of the Winter Sports Center of the State Sports General Administration, and president of the Endoscopic Ultrasound Branch of the Beijing Medical Doctor Association.

He has long been engaged in clinical and basic research work related to the systemic diagnosis and treatment of early digestive system cancer. He is proficient in all advanced endoscopic procedures, ESD, ERCP, EUS and related interventional treatments. He has presided over 2 national key research and development plan, 3 national natural science projects. The total project funding is more than 40 million yuan. As a corresponding author, he published 132 SCI papers in authoritative journals such as Ann Intern Med, JEV, Oncogene, GIE, Am J Gastroenterol, with a highest IF 51.58, total IF 550.71. He has edited and (or) participated in the editing of 9 guidelines and monographs, and obtained 7 national invention patents. He has won awards such as the "Third Prize of Beijing Science and Technology Progress Award", "Second Prize of Huaxia Medical Science and Technology Award", and "Second Prize of National Teaching Achievement of Higher Education (Postgraduate)".

He developed the first systematic and standard domestic endoscopy evaluation system in China, created the first domestic digestive endoscopy evaluation and training and promotion platform; established the largest research cohort in Handan and Wu'an, Hebei, the country's largest esophageal squamous cell carcinoma high-incidence area; carried out training for grassroots physicians across the country and digestive physicians from countries along the "Belt and Road".
Rong LIN
Rong LIN
Union Hospital, Tongji Medical College of Huazhong University of Science and Technology
China
Rong LIN
Rong LIN
Union Hospital, Tongji Medical College of Huazhong University of Science and Technology
  • Director of Department of Gastroenterology and Endoscopy Center
• Member, Chinese Society of Gastroenterology
• Standing Committee Member, Chinese Endoscopist Association
• Standing Committee Member, Society of Oncological Endoscopy, CACA
• Member of the Standing Committee, Deputy Secretary-General, Society of Digestive Endoscopy, Health Exchange and Cooperation Across the Taiwan Straits
• Chair-Elect, Society of Gastroenterology, HuBei Medical Doctor Association
• Changjiang Young Scholar, Ministry of Education; Outstanding Youth of Hubei Province; Chief of Hubei Provincial Innovation Research Group
• Principal Investigator of Key Research and Development Program of the 14th Five-Year Plan
Ying-hong Lu
Ying-hong Lu
The Chinese University of Hong Kong
Hong Kong, China
Ying-hong Lu
Ying-hong Lu
The Chinese University of Hong Kong
  • PhD student, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease
Ying-hong Lu is currently a PhD student at the Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong. She obtained her Master's degree from Fudan University and her bachelor’s degree from Huazhong University of Science and Technology.

Her research interests focus on leveraging multi-omics sequencing technologies, including metagenome, transcriptome, metabolomics, and single-cell approaches, to investigate the role of microbiota in tumor progression, particularly tumor metastasis. She has published a paper exploring the spatial heterogeneity of intratumoral bacteria in liver cancer in Cancer Discovery as first author in 2025. She is also the winner of the GUT-IDDF Young Investigator Award, IDDF 2024, and presented her work in Digestive Disease Week 2024, IDDF 2024, and China Gut 2025.
Xiong MA
Xiong MA
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Institute of Digestive Disease
China
Xiong MA
Xiong MA
Renji Hospital, Shanghai Jiao Tong University School of Medicine
  • Director, Department of Gastroenterology and Hepatology
Shanghai Institute of Digestive Disease
  • Vice-Director
Xiong Ma, MD, PhD earned his under-graduated degree from Zhenjiang Medical College in 1991 and received his doctorate degree from Shanghai Jiao Tong University School of Medicine in 2001. Since then, Dr Ma has worked at Shanghai Renji Hospital, Shanghai Institute of Digestive Disease as attending physician, associate professor and researcher. From 2005 to 2006, he was trained as postdoctoral fellow at the Johns Hopkins University School of Medicine.

Dr Ma’s research interests are mainly focused on autoimmune liver diseases and nonalcoholic fatty liver disease. He has received 7 grants from the National Natural Science Foundation of China, and the National Distinguished Young Scholarship in 2013. Dr Ma has more than 80 peer-reviewed papers in English published in international journals including Gastroenterology, Journal of Hepatology, Gut, Hepatology, Nature Communications and Journal of Autoimmunity.
Fernando MAGRO
Fernando MAGRO
São João University Hospital, Porto
Portuguese IBD Study Group (GEDII)
Portugal
Fernando MAGRO
Fernando MAGRO
São João University Hospital, Porto
  • Consultant in Gastroenterology and Director of the Clinical Pharmacology Unit
Portuguese IBD Study Group (GEDII)
  • Founder, Board member, and Research Head
Fernando Magro is a Consultant in Gastroenterology and Director of the Clinical Pharmacology Unit, at the São João University Hospital in Porto, Portugal. He’s a founder, board member, and research head of the Portuguese IBD Study Group (GEDII). He’s a Full Professor with Tenure at the Faculty of Medicine of the University of Porto (FMUP). Internationally, he was appointed President of the European Crohn's and Colitis Organization (ECCO). He also serves as a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).

Since 1995, his interest lies in Inflammatory Bowel Disease (IBD) and intestinal epithelial inflammation. With his colleagues at GEDII and FMUP, he has developed several studies correlating drug levels to new serum and fecal biomarkers.

Professor Magro has published over 400 manuscripts and has more than 23,000 citations.
Joyce MAK
Joyce MAK
Prince of Wales Hospital, Hong Kong
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Joyce MAK
Joyce MAK
Prince of Wales Hospital, Hong Kong
  • Consultant at Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics
The Chinese University of Hong Kong, Hong Kong
  • Honorary Clinical Assistant Professor, Department of Medicine & Therapeutics
Dr. Joyce Wing Yan Mak is currently the Consultant at Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics at Prince of Wales Hospital. She is also the Honorary Clinical Associate Professor at Department of Medicine and Therapeutics at the Chinese University of Hong Kong. She graduated from the University of Hong Kong in 2008 and trained as a gastroenterologist. She was elected to be the Fellow of the Hong Kong College of Physicians in 2015. She is passionate about inflammatory bowel disease and gut microbiota. She worked as an honorary clinical research fellow in Inflammatory Bowel Disease Unit in St. Marks Academic Institute, London and honorary research fellow in IBD Unit in University of Chicago. She further obtained her PhD in Medical Sciences in inflammatory bowel disease in CUHK in 2022. She has published over 50 articles in peer-reviewed journals on inflammatory bowel disease and gut microbiota, including Lancet Gastroenterology and Hepatology and 3 book chapters on inflammatory bowel disease. She is currently the President of the Hong Kong IBD Society and serves as an Associate Editor for Frontline Gastroenterology, and editorial board member of Alimentary Pharmacology and Therapeutics (APT). She is also a board member of the Asian Organisation of Crohn’s and Colitis (AOCC).
Steve MAO
Steve MAO
Cell Press, Cambridge
USA
Steve MAO
Steve MAO
Cell Press, Cambridge
  • Editor-in-chief
After receiving a PhD in cell biology from UT Southwestern, Steve Mao did his postdoctoral work at Cold Spring Harbor Laboratory and Harvard University. Steve was a senior editor at Cell and Science before joining Cancer Cell in 2020.
Zhe-chuan MEI
Zhe-chuan MEI
Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University
National Key R&D Program of China (Ministry of Science and Technology)
China
Zhe-chuan MEI
Zhe-chuan MEI
Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University
  • Professor, Chief Physician and PhD Supervisor
National Key R&D Program of China (Ministry of Science and Technology)
  • Principal Investigator
Academic & Professional Titles

- Professor, Chief Physician and PhD Supervisor
- Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University

Key Leadership Roles

- Principal Investigator, National Key R&D Program of China (Ministry of Science and Technology)
- Standing Committee Member, Chinese Medical Doctor Association - Digestive Branch
- Standing Committee Member, Chinese Medical Doctor Association - Endoscopist Branch
- Standing Committee Member, Digestive Diseases Committee, China International - Exchange and Promotive Association for Medical and Health Care
- Expert Panel Member, Digestive Endoscopy Quality Control Center, National Health Commission
- Committee Member, Chinese Society of Digestive Endoscopy (CSDE)
- Group leader, Cleaning and Disinfection Working Group, CSDE
- Vice President, Chongqing Medical Doctor Association
Jian-lin REN
Jian-lin REN
Zhongshan Hospital Affiliated to Xiamen University
Institute of Digestive Diseases, Xiamen University
China
Jian-lin REN
Jian-lin REN
Zhongshan Hospital Affiliated to Xiamen University
  • Deputy Director
Institute of Digestive Diseases, Xiamen University
  • Director
- Professor (Level II), Chief Physician, Doctoral Supervisor

- Minjiang Scholar; National Health Commission Outstanding Contribution Award for Middle-aged and Young Experts; Expert Receiving State Council Special Allowance.

- Deputy Director, Zhongshan Hospital Affiliated to Xiamen University.

- Director, Institute of Digestive Diseases, Xiamen University.

- Director, Institute of Microecology, Xiamen University School of Medicine.

- Director, Department of Gastroenterology, Xiamen University School of Medicine, National Clinical Key Specialty.

- Director, Fujian Branch, National Clinical Research Center for Digestive Diseases.
Standing Committee Member, Endoscopists Branch, Chinese Medical Doctor Association.

- Vice Chairman, Endoscopic Artificial Intelligence Committee, Chinese Medical Doctor Association.

- Vice Leader, Rare Diseases Collaboration Group, Gastroenterology Branch, Chinese Medical Association.

- Chairman, Gastroenterology Branch, Cross-Strait Medical and Health Exchange Association.

- Vice Chairman, Digestive Diseases Branch, China International Exchange Association for Healthcare; Chairman, Microecology Group.

- Executive Vice Chairman, Microecology Healthcare Committee, China Society for Promotion of Science and Technology Commercialization.

- Committee Member, Clinical Practice Guidance Committee, Ministry of Education of China.

- Expert Committee Member, Cross-Strait Synergy Center for Peaceful Development.

- Executive Chairman, Cross-Strait Digestive Forum and World Chinese Digestive Innovation Forum
Shintaro SAGAMI
Shintaro SAGAMI
International Bowel Ultrasound (IBUS) Group
IUS Working Group of the Asian Organization for Crohn’s and Colitis (AOCC)
Kitasato University Kitasato Institute Hospital, Tokyo
Japan
Shintaro SAGAMI
Shintaro SAGAMI
International Bowel Ultrasound (IBUS) Group
  • Scientific Committee (SciCom)
IUS Working Group of the Asian Organization for Crohn’s and Colitis (AOCC)
  • Governing Board Member
Kitasato University Kitasato Institute Hospital, Tokyo
  • Vice-Director
Dr. Shintaro Sagami, MD, PhD, is a leading expert in inflammatory bowel disease (IBD) with a strong focus on intestinal ultrasound (IUS). He has been performing IUS since 2007 and has concentrated his clinical and academic activities in this area since 2013. Dr. Sagami currently serves on the Scientific Committee (SciCom) of the International Bowel Ultrasound (IBUS) Group and is a Governing Board Member of the IUS Working Group of the Asian Organization for Crohn’s and Colitis (AOCC). Based at the Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Tokyo, he leads numerous multicenter IUS-based studies with active collaborations across Asia and North America. In addition to intestinal ultrasound, his research encompasses MR enterography (MRE) and IBD biomarkers, aiming to enhance non-invasive disease monitoring. He has a particular interest in advanced imaging techniques such as transperineal ultrasound, shear wave elastography, and contrast-enhanced ultrasound, and contributes extensively to international efforts toward standardization and innovation in IBD diagnostics.
Roy SOETIKNO
Roy SOETIKNO
University of California San Francisco
Northwestern University
University of Indonesia
USA
Roy SOETIKNO
Roy SOETIKNO
University of California San Francisco
  • Clinical Professor of Medicine
Northwestern University
  • Adjunct Professor of Medical Education
University of Indonesia
  • Adjunct Professor of Medical Education
Roy Soetikno, MD, MS, MASGE, is Clinical Professor of Medicine at the University of California San Francisco. He is also an Adjunct professor of medical education at Northwestern University and an Adjunct professor of medicine at the University of Indonesia.

Roy started his career at Stanford School of Medicine where he served as Chief of Endoscopy and Chief of the Gastroenterology Section at the VA Palo Alto and professor of medicine at Stanford. He specializes in advanced diagnostic and therapeutic endoscopy with specific expertise is in the detection and resection of early gastrointestinal cancers. Trained in outcomes research, he led a team that showed the prevalence and importance of flat colon polyps in the United States. His contribution brought a worldwide recognition of the critical relationship of easy-to-miss flat polyps and colon cancer. Dr. Soetikno is a passionate teacher of endoscopy and is internationally renowned for his efforts to disseminate knowledge about simulation learning and endoscopy.
Rhonda SOUZA
Rhonda SOUZA
Texas A&M University College of Medicine
Baylor University Medical Center
Baylor Scott & White Research Institute
USA
Rhonda SOUZA
Rhonda SOUZA
Texas A&M University College of Medicine
  • Professor of Medicine
Baylor University Medical Center
  • Co-Director, Center for Esophageal Diseases
Baylor Scott & White Research Institute
  • Co-Director, Center for Esophageal Research
Dr. Rhonda Souza, M.D. is Co-Director of the Center for Esophageal Diseases at Baylor University Medical Center at Dallas, Co-Director of the Center for Esophageal Research at the Baylor Scott & White Research Institute, and Professor of Medicine at Texas A&M School of Medicine. Prior to joining Baylor University Medical Center in January 2017, Dr. Souza was Professor of Medicine at the University of Texas Southwestern Medical Center and the Dallas VA Medical Center.

Dr. Souza’s laboratory has focused primarily on disorders of the esophagus, especially GERD and its complications including Barrett’s esophagus and esophageal adenocarcinoma, as well as eosinophilic esophagitis and esophageal motility disorders. For over 20 years, she has worked closely with her scientific partner, Dr. Stuart Spechler, to establish a translational research center that incorporates cell culture models, animal models, and in vivo patient studies to answer research questions regarding esophageal diseases. Their studies in rats and humans suggest that reflux esophagitis develops as a cytokine-mediated inflammatory injury, rather than a caustic chemical injury, challenging decades of dogma on the role of acid in reflux esophagitis. Her team has uncovered that squamous epithelial progenitor cells from esophageal submucosal gland ducts contribute to esophageal re-epithelialization following radiofrequency ablation of non-dysplastic Barrett’s esophagus, providing a potential source for the origin of Barrett’s esophagus in humans. Most recently, her lab has elucidated mechanisms whereby substances produced by the esophagogastric fat pad of obese patients impair esophageal barrier integrity, independent of GERD, and propose a new concept for the pathogenesis of dilated intercellular spaces uncovering a role for cytoskeletal contraction of squamous cells that expands their intercellular spaces, challenging decades of dogma on the caustic damage caused by refluxed acid and pepsin on intercellular junctional complexes.

Her truly translational approach to research in GERD and Barrett’s esophagus has allowed her to contribute to numerous publications on the clinical science of Barrett’s esophagus including co-authoring the 2011 AGA guidelines for management of Barrett’s esophagus and the 2022 guidelines for the American College of Gastroenterology on the management of Barrett’s esophagus, in which her focus is on the role of biomarkers in predicting cancer progression. She is currently a multi-PI on a NIH-funded U01 trial entitled “A Multicenter Randomized Controlled Trial of Surveillance versus Endoscopic Therapy for Barrett’s Esophagus with Low-Grade Dysplasia: The SURVENT Trial” and a R01 entitled “Stratification of Cancer Risk in Patients with Non-Dysplastic Barrett’s Esophagus using TissueCypher: The SCRiBE study”.

Dr. Souza has published more than 150 scientific reports, editorials, review articles, and book chapters on esophageal disorders. In 2010, she was elected to the American Society of Clinical Investigation. Dr. Souza is the 2025 recipient of the John S. Fordtran Gastrointestinal and Liver Section Distinguished Research Award by the American Physiology Society, and the Morton I. Grossman Awardee for outstanding research related to the discipline of gastroenterology by the American Gastroenterological Association (AGA). She has more than 20 years of leadership experience, and recently completed a 6-year term as Council Chair for the AGA.
Joseph SUNG
Joseph SUNG
Nanyang Technological University
Singapore
Joseph SUNG
Joseph SUNG
Nanyang Technological University
  • Distinguished University Professor
  • Senior Vice President (Health & Life Sciences)
  • Dean, Lee Kong Chian School of Medicine
Professor Sung is currently a Distinguished University Professor, Senior Vice President (Health & Life Sciences), and Dean of the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore.



He obtained his medical degree (MBBS) from The University of Hong Kong and was awarded a PhD in Biomedical Sciences by the University of Calgary and an MD by The Chinese University of Hong Kong. From 2010 to 2017, he served as the Vice-Chancellor and President of The Chinese University of Hong Kong.



Professor Sung's research interests include intestinal bleeding, Helicobacter pylori, peptic ulcers, hepatitis B, colorectal cancer, and other cancers of the digestive system. In recent years, his work has expanded to studies on the gut microbiome, digestive diseases, and the application of artificial intelligence in clinical medicine. He has authored over 1,000 scientific articles published in leading medical and scientific journals. His most recent book, “Artificial Intelligence in Medicine: From Ethical, Social, and Legal Perspectives”, was published in 2024.



Professor Sung has been recognized as a "Highly Cited Researcher" by Clarivate Analytics for the consecutive years from 2018 to 2024.
Cheng-wei TANG
Cheng-wei TANG
China Society of Gastroenterology
APAGE
China
Cheng-wei TANG
Cheng-wei TANG
China Society of Gastroenterology
  • President
APAGE
  • Council Member
- President, China Society of Gastroenterology.​
- Council Member, APAGE.​
- Committee Member, WGO.​
- Academic Chief of Department Gastroenterology & Hepatology, West China Hospital, Sichuan University, China.
Raymond TANG
Raymond TANG
The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Hong Kong
Hong Kong, China
Raymond TANG
Raymond TANG
The Chinese University of Hong Kong, Hong Kong
  • Director, S.H. Ho Center for Digestive Health
  • Assistant Professor, Department of Medicine and Therapeutics
Prince of Wales Hospital, Hong Kong
  • Deputy Director, Endoscopy Center
Dr. Raymond Tang is currently an Assistant Professor in the Department of Medicine and Therapeutics of The Chinese University of Hong Kong, Deputy Director of Endoscopy Center at the Prince of Wales Hospital, and Director of S.H. Ho Center for Digestive Health. Dr. Tang received his M.D. degree from University of Southern California, Keck School of Medicine in 2004 and was selected to the Alpha Omega Alpha Honor Medical Society. He completed his internal medicine residency at the University of California, Los Angeles Medical Center in 2007 and completed his gastroenterology and hepatology fellowship at the University of California, San Diego Medical Center in 2010. Dr. Tang subsequently pursued training in advanced endoscopy with focus on EUS, ERCP and balloon-assisted enteroscopy at University of California, San Diego Medical Center in 2010 - 2011. He is board certified in Internal Medicine and Gastroenterology in the American Board of Internal Medicine.


Dr. Tang’s clinical and research interests include advanced diagnostic and interventional EUS and ERCP, pancreatic cystic neoplasms, as well as novel technology in advanced endoscopy training and colorectal cancer screening. He has authored papers and book chapters on topics of EUS, ERCP, pancreatic cystic neoplasms, novel technology in colorectal cancer screening, and advanced endoscopy training.


Dr. Tang has been actively involved in education and research in endoscopy. He is currently a faculty member of the Asian EUS Group, a member of the education committee and the green endoscopy committee of the Asian Pacific Society for Digestive Endoscopy, and the honorary treasurer & council member of the Hong Kong Society of Endosonography.
Anthony TEOH
Anthony TEOH
Hong Kong Sanatorium Hospital
WEO Research Subcommittee
Hong Kong, China
Anthony TEOH
Anthony TEOH
Hong Kong Sanatorium Hospital
  • Honorary Consultant Surgeon
WEO Research Subcommittee
  • Chairman
Anthony Teoh is currently an Honorary Consultant Surgeon in the Hong Kong Sanatorium Hospital. He was previously the Deputy Director of Endoscopy and Professor in The Chinese University of Hong Kong. He is also the Chairman of the WEO research subcommittee, President of the Hong Kong Hernia Society and Vice president of the Asian EUS group. He also serves as Secretary to the Hong Kong EUS society. He is also a council member of the Hong Kong College of Surgeons, Hong Kong Hernia society, Hong Kong society of Robotic surgery and Hong Kong Society of Digestive Endoscopy. He graduated from the Chinese University of Hong Kong in 2001. After completing his surgical training, he has received overseas training in many international centres including the Kitasato University East Hospital and the Cancer Institute Hospital (Ariake) in Japan, the University of Washington, Cornell University and Stanford University in USA. His research interests are multifold and these include advanced interventional endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiography (ERCP), minimally invasive upper gastrointestinal cancer surgery, hernia surgery and robotics surgery. He is a winner of multiple awards including 2019 Asian Pacific Digestive Week Emerging Leaders Lectureship, Carlos Pellegrini Traveling Fellow, American Society for Gastrointestinal Endoscopy endoscopic research awards, the GB Ong and Li Shield’s Medal (best candidate in the fellowship examinations both locally and internationally). He has served as a Visiting Professor to the Stanford Medical Center, Fujian University Medical Hospital, Consultant for Hepatopancreatobiliary Minimally Invasive Surgery Institute of Central South University. In addition, he is currently an Associate Editor for Gastrointestinal Endoscopy, Digestive Endoscopy, Endoscopy International Open and Techniques in Gastrointestinal Endoscopy. His other editorial board experiences include several internationally renowned journals: Clinical gastroenterology and hepatology, VideoGIE, Endoscopic ultrasound, Saudi journal of gastroenterology, World journal of Gastrointestinal endoscopy and World Journal of Gastroenterology. He has obtained over $10 million HKD in research grants, published over 180 journal papers and written 22 book chapters. He is currently a Consultant for Boston Scientific, Cook, Taewoong, Microtech, M.I. Tech and CMR Medical Corporations.
Gui-qi WANG
Gui-qi WANG
Cancer Hospital, National Cancer Center, Chinese Academy of Medical Science
Expert Committee of the Early Diagnosis and Treatment of Cancer Project (Rural Areas) of the National Major Program for Public Health
China
Gui-qi WANG
Gui-qi WANG
Cancer Hospital, National Cancer Center, Chinese Academy of Medical Science
  • Professor, Endoscopy Department
Expert Committee of the Early Diagnosis and Treatment of Cancer Project (Rural Areas) of the National Major Program for Public Health
  • Member
- Professor, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Science, Endoscopy Department

- Member, Committee of the National Committee of the CPPCC

- Chairman, Expert Committee of the Early Diagnosis and Treatment of Cancer Project (Rural Areas) of the National Major Program for Public Health

- Chairman, Committee on Cancer Screening and Early Diagnosis of the Chinese Preventive Medical Association

- Chairman, National Working Committee on Health Management of Chronic Diseases -- Cancer Screening and Early Diagnosis Training

- Candidate Chairman, Committee on Gastrointestinal Endoscopy of the Chinese Medical Association Beijing Branch

- Inaugural Chairman, Professional Committee of Tumor Endoscopy, Chinese Anti-Cancer Society

- Director, Gastrointestinal Cancer Screening Collaborative Group of the Committee of Gastrointestinal Endoscopy of the Chinese Medical Association
Hsiu-po WANG
Hsiu-po WANG
Taiwan Interventional Pancreatobiliary Endoscopy Society (TIPES)
Internal Medicine, College of Medicine, National Taiwan University
Taiwan, China
Hsiu-po WANG
Hsiu-po WANG
Taiwan Interventional Pancreatobiliary Endoscopy Society (TIPES)
  • President
Internal Medicine, College of Medicine, National Taiwan University
  • Professor
Prof. Hsiu-Po Wang, born in 1961, graduated from the College of Medicine, National Taiwan University in 1988. He completed residency and GI fellow training in 1993. Professor Wang is the current President of Taiwan Interventional Pancreatobiliary Endoscopy Society (TIPES) and Professor of Internal Medicine, College of Medicine, National Taiwan University. He is the current Director and the former President of the Digestive Endoscopy Society of Taiwan (DEST), the former Supervisor of Gastroenterology Society of Taiwan (GEST), the Executive Director of Taiwan Pancreas Society, and he Executive Director of the Taiwan Neuroendocrine Tumor Association (T-NET). Internationally, the current member of steering committee of Asian EUS Group (AEG) since 2013. After training of gastroenterology in 1993, he serviced in the Division of Gastroenterology, Department of Internal Medicine and Emergency Department of National Taiwan University Hospital at the same time for 14 years and then became the Chief of Division of Endoscopy of National Taiwan University Hospital until 2020 and then the Chief of Department of Gastroenterology and Hepatology for 2 years. Besides his majors of ERCP and EUS/interventional EUS, he also involves emergent endoscopic procedures, IEE, endoscopic tumor ablation – APC/RFA/laser of esophagus/biliary/pancreas, enteroscopy/capsule endoscopy, GI stenting. He has been active in many international meetings and has been invited for chair, speech and live demonstration. He has had more than 500 publications including international textbooks.
Liang-jing WANG
Liang-jing WANG
The Second Affiliated Hospital of Zhejiang University School of Medicine
Chinese Society of Gastroenterology
China
Liang-jing WANG
Liang-jing WANG
The Second Affiliated Hospital of Zhejiang University School of Medicine
  • Chief Physician of Gastroenterology Department
  • Vice President
Chinese Society of Gastroenterology
  • Committee
Liangjing Wang, MD., PhD., Chief Physician of Gastroenterology Department, Vice President of the Second Affiliated Hospital of Zhejiang University School of Medicine. He is the committee of Chinese Society of Gastroenterology and the Chairman of Zhejiang Medical Association of Gastroenterology. He focuses on the early diagnosis and endoscopic treatment of gastric and colorectal cancer, translational study of gut microbiota and cancer immunotherapy. He has published more than 50 research articles in Cell, Nat Aging, Nat Commun, J Clin Invest as the corresponding author.
Dennis WONG
Dennis WONG
The Chinese University of Hong Kong
Hong Kong, China
Dennis WONG
Dennis WONG
The Chinese University of Hong Kong
  • Associate Professor, Department of Medicine & Therapeutics
Dennis Wong obtained his BSc and M.Phil. degrees from the University of Hong Kong before completing a Ph.D. in the University of Leeds, UK in 2011. He joined the Chinese University of Hong Kong in 2013. Since 2024, He is Associate Professor in Department of Medicine & Therapeutics and a member of the State Key Laboratory of Digestive Disease at the CUHK. His research interests are primarily in the field of gastrointestinal cancers, trying to understand their molecular basis and develop therapeutic strategies to inhibit tumorigenesis, ultimately contributing to improved patient care. He has published >120 peer-reviewed articles in international journals, including Cell, Cancer Cell, Nat Rev Clin Oncol, Cell Host Microbe, Nat Microbiol, Sci Transl Med, Gastroenterology, Gut, Hepatology, Nat Commun, etc.
Marc WONG
Marc WONG
Prince of Wales Hospital, Hong Kong
Hong Kong, China
Marc WONG
Marc WONG
Prince of Wales Hospital, Hong Kong
  • Associate Consultant, Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics
Marc Wong graduated from the Li Ka Shing Faculty of Medicine, the University of Hong Kong in 2009, receiving two scholarships and the Woo Kai Fun Prize. He completed his training in Gastroenterology and Hepatology in 2016 before joining the Department of Medicine and Therapeutics, Prince of Wale Hospital as a Resident Specialist in 2018. Dr Wong is currently Associate Consultant of Department of Medicine and Therapeutics at Prince of Wales Hospital and in charge of the Motility services in Prince of Wales Hospital, with special focus on oesophageal motility disorders and gastro-oesophageal reflux disease (GERD). His work includes collaboration with the Flinders University, Australia on pharyngeal manometry and is the first in Asia to have performed the FLIP topography using the EndoFLIP 2.0 system. Marc also has strong interest in advanced endoscopy including EUS and ERCP. He has been nominated for various international Train-the-Trainer Courses on EUS.
Sunny WONG
Sunny WONG
Nanyang Technological University
Singapore
Sunny WONG
Sunny WONG
Nanyang Technological University
  • Associate Professor, Lee Kong Chian School of Medicine
Dr Sunny Wong is an Associate Professor at the Lee Kong Chian School of Medicine, Nanyang Technological University Singapore. He received his MBChB at the Chinese University of Hong Kong, and his PhD in University of Oxford on genetics of bacterial infections. He completed his clinical training in gastroenterology in the Prince of Wales Hospital in Hong Kong. His main research interest is on gut microbiome, investigating the host-microbe interaction in digestive and metabolic diseases, and exploring this for discovery of novel biomarkers and therapeutics. He has won several awards, including the Asia Pacific Digestive Week Emerging Leaders Lectureship (2021), the Hong Kong College of Physicians Sir David Todd Lectureship (2020) and the Croucher Foundation Award (2014). He has published over 200 peer-reviewed articles including papers in Nature Genetics, Nature Communications, Gastroenterology and Gut, and is currently an Associate Editor for the Journal of Gastroenterology and Hepatology.
Vincent WONG
Vincent WONG
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Vincent WONG
Vincent WONG
The Chinese University of Hong Kong, Hong Kong
  • Mok Hing Yiu Professor of Medicine
  • Head (Academic) of the Division of Gastroenterology and Hepatology
Vincent Wong holds the position of Mok Hing Yiu Professor of Medicine and serves as the Head (Academic) of the Division of Gastroenterology and Hepatology at The Chinese University of Hong Kong. His research primarily revolves around steatotic liver disease and liver fibrosis, with a particular focus on the development and application of non-invasive tests for screening, diagnosis and prognostication. Notably, he contributed to the writing committee responsible for formulating the guidelines of the Asian Pacific Association for the Study of the Liver, American Gastroenterological Association and the European Association for the Study of the Liver. He has authored more than 650 publications in international medical journals. His h-index by Google Scholar is 135 as of March 2025. He holds the position of associate editor for the Journal of Hepatology and serves as an editorial board member for renowned publications such as Gastroenterology, JHEP Reports, and Clinical and Molecular Hepatology. He was the president of the Hong Kong Association for the Study of Liver Diseases from 2015 to 2017 and the Chairman of the Specialty Board of Gastroenterology and Hepatology at the Hong Kong College of Physicians from 2022 to 2025. He has been honoured with research awards from esteemed organizations such as the Asian Pacific Association for the Study of the Liver, Asian Pacific Digestive Week Federation, British Society of Gastroenterology, Hong Kong College of Physicians, the Health Bureau of the Hong Kong SAR Government, and the Ministry of Science and Technology and the Ministry of Education of China.
Chun-ying WU
Chun-ying WU
Taipei Veterans General Hospital
National Ying Ming Chiao Tung University (NYCU)
Taiwan, China
Chun-ying WU
Chun-ying WU
Taipei Veterans General Hospital
  • Chair Professor, Department of Gastroenterology
National Ying Ming Chiao Tung University (NYCU)
  • Director, Institute Biomedical Informatics
  • Director, Health Innovation Center and Microbiota Research Center
Chun-ying Wu received his M.D. degree from the National Taiwan University (NTU) in 1991, M.P.H. degree from Harvard School of Public Health in 1993, and Ph.D. degree from NTU in 2007.

He currently is the Director, Institute Biomedical Informatics at National Ying Ming Chiao Tung University (NYCU). He is also appointed as Director at the Health Innovation Center and Microbiota Research Center in the NYCU.

Professor Wu has positions as Director, National Human Microbiota Core Facility, National Science and Technology Council and the Professor at the Division of Translational Research in Taipei Veterans General Hospital. He has established Taiwan Microbiome Consortium and currently serves as the first President in the consortium.

He received an Outstanding Research Award in 2015 and 2021 at Taiwan National Science & Technology Council. In 2018, he received Medical Model Award presented by Taiwan Medical Association. He also received National Innovation Awards from Taiwan Institute for Biotechnology & Medicine Industry in 2016 and Emerging Leadership Lectureship Award in 2015 given by Asian Pacific Association of Gastroenterology.

Professor Wu’s research interests focus on digestive cancer and microbiota. Prof. Wu has published hundreds of articles in top-ranking journals, such as JAMA, JAMA Int Med, JAMA Ped, J Clinical Oncology, Gastroenterology, Gut, J of Hepatology, Hepatology, etc. with H-index=64 and more than 14,000 citations.
Dong WU
Dong WU
Peking Union Medical College Hospital
China
Dong WU
Dong WU
Peking Union Medical College Hospital
  • Vice President
Professor of Medicine
Vice President of Peking Union Medical College Hospital
Published over 200 papers in national and international peer-reviewed journals and dozens of chapters of textbooks
42 patents in the field of GI Endoscopy and Pancreatology
Major research interest includes gut microbiome, pancreatology, and GI endoscopy
An enthusiastic medical educator
Edmund WU
Edmund WU
Medicine & Geriatrics at Princess Margaret Hospital
The Chinese University of Hong Kong
Hong Kong, China
Edmund WU
Edmund WU
Medicine & Geriatrics at Princess Margaret Hospital
  • Associate Consultant, Department of Medicine & Geriatrics
The Chinese University of Hong Kong
  • Honorary Assistant Professor, Department of Medicine & Therapeutics
Dr. Edmund Wu is an Associate Consultant in the Department of Medicine & Geriatrics at Princess Margaret Hospital and an Honorary Assistant Professor in the Department of Medicine & Therapeutics at the Chinese University of Hong Kong. He has a special interest in inflammatory bowel disease, and serves on the council of the Hong Kong IBD Society. Dr. Wu pursued specialized training in intestinal ultrasound (IUS) in Italy and Germany, becoming the first gastroenterologist in Hong Kong certified by the International Bowel Ultrasound Group (IBUS). Dr. Wu has been actively involved with IBUS, serving as a teaching faculty member for the first three IBUS hands-on IUS workshops in Asia, held in India, Japan, and Hong Kong. Additionally, Dr. Wu established Hong Kong’s first IBUS training center at Princess Margaret Hospital. Since its inception, he has been providing bedside IUS teaching to gastroenterologists from various hospitals across Hong Kong.
Justin WU
Justin WU
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Justin WU
Justin WU
The Chinese University of Hong Kong, Hong Kong
  • Associate Dean (Health Systems), Department of Medicine & Therapeutics
Justin Wu is the Associate Dean (Health Systems) of Faculty of Medicine of CUHK. He is responsible for the development of an ecosystem of healthcare services and medical technology of CUHK Medicine in Hong Kong, Greater Bay Area and beyond.

Professor Wu has academic focus in functional gastrointestinal disorders and gastroesophageal reflux disease. He is serving as academic leader in many international and local professional organizations, which include the President of Asian Pacific Digestive Week, the Past President of Asian Pacific Association of Gastroenterology, and the Past President of Hong Kong Society of Gastroenterology.
Hon-chi YIP
Hon-chi YIP
The Chinese University of Hong Kong, Hong Kong
Prince of Wales Hospital, Hong Kong
Hong Kong, China
Hon-chi YIP
Hon-chi YIP
The Chinese University of Hong Kong, Hong Kong
  • Clinical Assistant Professor, Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery
Prince of Wales Hospital, Hong Kong
  • Deputy Director of the Shaw Combined Endoscopy Center
  • Honorary Associate Consultant
Hon-chi Yip is currently Clinical Assistant Professor at the Division of Upper Gastrointestinal and Metabolic Surgery, Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong. He is also serving as Deputy Director of the Shaw combined endoscopy center and Honorary Associate Consultant at the Prince of Wales Hospital.



Dr. Yip graduated from the Chinese University of Hong Kong in 2008 with honors. He received the RC Li Gold Medal in Surgery. He joined the Department of Surgery at Prince of Wales Hospital after graduation and obtained the fellowship in General Surgery in 2015.



Focusing on Upper Gastrointestinal Tract Cancer management, Dr. Yip underwent overseas training in Osaka and Tokyo, Japan in 2017. His current research focuses on endoscopic diagnosis and treatment of early gastrointestinal cancer, as well as minimally invasive and robotic techniques in surgical treatment of gastric and esophageal neoplasia.



Dr. Yip is engaged in regional education and training. He serves in the steering committee of the Asian Novel Bio-imaging and Intervention Group (ANBIIG), an Asian wide organization focusing on endoscopic diagnosis and treatment of GI luminal diseases. He is a member of the Education Committee in the Asia-Pacific Society of Digestive Endoscopy (APSDE). He is currently board member of the Asia-Pacific Endo-Laparoscopic Surgery Group (APELS), Guidelines Committee member of International Society for Diseases of the Esophagus (ISDE), member of the Academy of Endoscopy (AoE), council member of Hong Kong Society of Digestive Endoscopy.
Terry YIP
Terry YIP
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Terry YIP
Terry YIP
The Chinese University of Hong Kong, Hong Kong
  • Assistant Professor, Department of Medicine & Therapeutics
Terry Yip is an Associate Professor in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong. Terry’s research interest is risk prediction in patients with chronic liver diseases by big healthcare database approaches. He has over 190 publications in peer-reviewed journals. He received the Young Investigator Award at APASL meetings in 2018, 2022, and 2023, The Best Poster Presentation Award: Viral Hepatitis - Clinical at EASL Congress 2024, and the Early Career Investigator Award in Clinical/Translational Science at AASLD meeting 2020. He is now a Statistical Consultant of the Journal of Hepatology, Statistical Editor of Clinical and Molecular Hepatology; and an Editorial Board member of Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Hepatology Communications, and Hepatoma Research.
Hon-ho YU
Hon-ho YU
Kiang Wu Hospital
University of Macau
Macau, China
Hon-ho YU
Hon-ho YU
Kiang Wu Hospital
  • Director of Internal Medicine Department
  • Consultant of Gastroenterology and Hepatology
University of Macau
  • Adjunct Associate Professor of Faculty of Health Science
Hon-ho Yu, Director of Internal medicine department, KWH (Kiang Wu Hospital ) and consultant of gastroenterology and hepatology in KWH. He also serve as Adjunct associate professor of Faculty of health science, University of Macau. His interest focusing on functional gastrointestinal diseases, refractory Helicobacter pylori infection, diagnosis, treatment and management of chronic hepatitis B and C, early screening of liver cancer, clinical diagnosis and management of fatty liver, diagnosis and treatment of liver fibrosis and cirrhosis. He has been responsible for one National Natural Science Foundation/Macao Science and Technology Development Fund joint project and three Macao Science and Technology Development Fund (FDCT) joint projects. He has published more than 40 articles at home and abroad. 
Hong-gang YU
Hong-gang YU
Renmin Hospital of Wuhan University
China
Hong-gang YU
Hong-gang YU
Renmin Hospital of Wuhan University
  • Chief of Gastroenterology Department; Professor, M.D. Tutor
Standing Committee Member of Chinese Society of Digestive Endoscopy

Chairman of Big Data Group of Chinese Society of Digestive Endoscopy

Chairman of Hubei Society of Digestive Endoscopy

Chairman of Hubei Digestive Endoscopy Intervention Quality Control Center

Evaluation Expert of National Digestive Endoscopy Improvement System
Jun YU
Jun YU
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Jun YU
Jun YU
The Chinese University of Hong Kong, Hong Kong
  • Choh-Ming Li Professor of Medicine and Therapeutics
  • Assistant Dean, Faculty of Medicine
  • Director, Institute of Digestive Disease
  • Director, State Key Laboratory Digestive Disease
Jun Yu is Choh-Ming Li Professor of Medicine and Therapeutics; Assistant Dean, Faculty of Medicine; Director, State Key Laboratory of Digestive Disease; Director, Institute of Digestive Disease; The Chinese university of Hong Kong (CUHK). She is a member of the European Academy of Sciences; member of Hong Kong Academy of Sciences; Member of the Chinese Academy of Medical Sciences; Chief editor of iMetaOmics, Associate Editor of Gut, Molecular Oncology, and Advisory Board of Cancer Cell.

Prof. Yu obtained MD and PhD at Tongji Medical University in 1994 and then embarked on gastrointestinal specialist in Beijing University, followed by postdoctoral fellowship in University of Magdeburg, Germany, CUHK and senior research officer at University of Sydney, Australia. She has been a CUHK faculty member since 2005 and a Professor of Department of Medicine and Therapeutics since 2011.

Her research interests being gut microbiota and genetic/epigenetic alterations in gastrointestinal cancers and fatty liver disease. She has published 632 articles (Cell, Cancer cell, Cell Metab, Nat Microbiol, Nat Metab) with over 51,600 citations (h-index 113) and earned over 50 major awards, including two National Natural Science Awards, He Liang He Li Award, Guanghua Engineering Prize, AGA Research Mentor Award USA, Croucher Senior Research Fellowship, and is a Clarivate Highly Cited Researcher.
Jennifer ZHANG
Jennifer ZHANG
The Chinese University of Hong Kong, Hong Kong
Hong Kong, China
Jennifer ZHANG
Jennifer ZHANG
The Chinese University of Hong Kong, Hong Kong
  • Assistant Professor, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease
Jennifer Zhang is an Assistant Professor at Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, CUHK. She is an awardee of the Excellent Young Scientists Fund by the National Natural Science Foundation of China (NSFC). Dr. Zhang serves as Youth Vice Chairman of the Gastroenterology Branch of the Cross-Strait Medical and Health Exchange Association and Council Member of Hong Kong Society for Immunology.

Her research interests focuses on metabolic dysfunction-associated steatotic liver diseases, particularly the mechanism, diagnosis, and treatment of MASH and its related HCC. She has published 83 papers (44 papers with IF > 10) in international peer-reviewed journals, including Cell, Cancer Cell, Cell Metabolism, Nature Metabolism, Journal of Hepatology, Gut, Gastroenterology. She has obtained over 20 awards including National Natural Sciences Award (Second-class) 2020; MOE Award (First-class) 2022; Hebei Province Science and Technology Progress Award (First-class) 2024, An Expertscape Expert in Fatty Liver 2022; and National Scholar Award 2015. She has secured 10 competitive grants as the principal investigator, including funding from GRF, HMRF, ITF and NSFC.


Her research interests primarily focuses on metabolic dysfunction-associated steatotic liver diseases, particularly the mechanism, diagnosis, and treatment of MASH and its related HCC. She has published 73 papers (38 papers with impact factor > 10) in international peer-reviewed journals, including Cell, Cancer Cell, Cell metabolism, Journal of Hepatology, Gut, Gastroenterology, and 5 book chapters. She has obtained over 20 awards including National Natural Sciences Award 2020; First-class MOE Award 2022; An Expertscape Expert in Fatty Liver 2022; and National Scholar Award 2015. She has secured 10 competitive grants as the principal investigator, including funding from GRF, HMRF, ITF and NSFC.
Minghua ZHENG
Minghua ZHENG
The First Affiliated Hospital of Wenzhou Medical University
China
Minghua ZHENG
Minghua ZHENG
The First Affiliated Hospital of Wenzhou Medical University
  • Professor of Medicine, Department of Hepatology
Ming-Hua Zheng is Professor of Medicine. He works in MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University. His research interests include clinical, basic and translational research on MASH. He has authored or co-authored over 200 peer-review papers, reviews and several consensuses/guidelines, including Nature, Cell, Science Translational Medicine, Nature Review Gastroenterology Hepatology, Nature Review Nephrology, Nature Review Endocrinology, Nature Communications, Journal of Clinical Investigation, Journal of Hepatology, Gut, Hepatology, Lancet Gastroenterology & hepatology, et al. He had founded the PERSONS platform and has dedicated to the development of its infrastructure since 2016-12-07. The platform is an ongoing prospective cohort consisting of more than 2000 cases of biopsy-proven MAFLD (2024-09-01) and supported by a multidisciplinary team. He is the member of Global MASH Council, Gut and Obesity Asia Workgroup, APASL MAIDEN, CHESS-MAFLD.
Ping-hong ZHOU
Ping-hong ZHOU
Zhongshan Hospital, Fudan University, Shanghai
Chinese Society of Digestive Endoscopy (CSDE)
China
Ping-hong ZHOU
Ping-hong ZHOU
Zhongshan Hospital, Fudan University, Shanghai
  • Professor of Surgery
  • Director & Chief of Endoscopy
Chinese Society of Digestive Endoscopy (CSDE)
  • Vice President
One of the early pioneers in China to carry out ESD, ESE & EFTRtreatment for early GI cancer and SMTs.

One of the international authorities on POEM.
Credited with performing the highest volume ofPOEM and EFTR/STER/NOTES cases in the world.

Chair of 1st to 17th Shanghai International Symposium ofEndoscopology(SISE) from 2007 to 2025.

Judge of World Cup ofEndoscopy,2016 DDW.
Chair ofASGE-CSDE symposium, 2017,2018 & 2021 DDW.

2019 National Science & Technology Progress Award.
Yin ZHU
Yin ZHU
The First Affiliated Hospital of Nanchang University
Jiangxi Provincial Quality Control Center for Gastroenterology and Digestive Endoscopy
China
Yin ZHU
Yin ZHU
The First Affiliated Hospital of Nanchang University
  • Vice President
  • Chief Physician in Gastroenterology
  • Second-Class Professor
  • PhD Supervisor
Jiangxi Provincial Quality Control Center for Gastroenterology and Digestive Endoscopy
  • Director
Prof. Yin Zhu is Vice President of The First Affiliated Hospital of Nanchang University, Chief Physician in Gastroenterology, Second-Class Professor, and PhD Supervisor. She serves as Director of Jiangxi Provincial Quality Control Center for Gastroenterology and Digestive Endoscopy, and completed postdoctoral training at the National Institutes of Health (USA).
With advanced endoscopic training from Emory University Hospital (USA) and Kanto NTT Hospital (Japan), Prof. Zhu has received numerous honors including National Outstanding Young Physician, Jiangxi Provincial Hundred-Thousand-Talent Scholar, and Jiangxi "Double Thousand Plan" Technological Innovation High-End Talent. Her academic leadership roles include serving as Standing Committee Member of the Chinese Society of Gastroenterology (CSGE) and Chair of its Pancreatic Diseases Study Group, Vice Chair of the Pancreatic Diseases Committee of the Chinese Medical Doctor Association, and Chair of the Gastroenterology Society of Jiangxi Medical Association.
She has secured six grants from the National Natural Science Foundation of China, published over 70 SCI-indexed papers as first or corresponding author, and received prestigious awards including First Prize of Jiangxi Science & Technology Progress Award and Second Prize of Ministry of Education Science & Technology Award. Her research focuses on severe acute pancreatitis management and Helicobacter pylori infection, with endoscopic expertise in early gastrointestinal cancer detection and endoscopic ultrasound applications.
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
Follow Us
#IDDF2025
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
About IDDF
The Organizer
The Organizing Committee
The Project Team
Venue
ATTENDING IDDF
Submit Abstracts
Submit Case Reports
Register
Accreditation
Programme
Speaker
PARTNERSHIP
Sponsors
Supporting Organization
MORE
Privacy Policy
Disclaimer
Contact Us
Follow Us
#IDDF2025
SECRETARIAT
MIMS (Hong Kong) Limited

Unit 2606-2609, 26/F, AIA Tower, 183 Electric Road,
North Point, Hong Kong
‍
E: info@iddforum.com
T: (852) 2116 4320
F: (852) 2559 6910
Organizers
PATRON:
Copyright © 2025. All Rights Reserved. Institute of Digestive Disease, The Chinese University of Hong Kong. Privacy | Disclaimer